分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Neuroprotective response against the onset of ischemic stroke by upregulation of histone H3Y99 sulfation

Li Jiang, Junchang Xie, Jianfeng Wang, Yili Yi, Runxin Zhou, Dingyuan Guo, Yu Wang, Xiao Zeng, Mingxuan Shi, Jianing Ding, Jiadi Wu, Jun Zhao, Siyu Feng, Nan Wang, Qian Shen, Yuping Yin, Mingchang Li

Journal:Cell Reports Medicine

IF:14

DOI:10.1016/j.xcrm.2026.102684

PMID:41850229

Published:2026-03-17

research field:神经科学分子生物学脑卒中研究代谢表观遗传学

Abstract

Protective cerebral responses against stresses are fundamental quests of medical science. Here, we report that upregulation of histone sulfation is a protective cerebral response against ischemic injury. Ischemia upregulates the SLC26A1-PAPSS1-SULT1B1 axis, which mediates the transportation of sulfate into cells, conversion of sulfate into PAPS, and catalysis of histone sulfation (H3Y99sulf) using PAPS, respectively. Upregulated H3Y99sulf promotes metabolic genes transcription and glycolysis, sustaining cell survival in ischemic stress. In the mouse model of transient middle cerebral artery occlusion, both PAPSS1 overexpression and sulfate supplementation can boost the neuroprotective H3Y99sulf mechanism, reduce brain injury, and improve neurological functions; disruption of H3Y99sulf exacerbates ischemia-induced brain injury and counteracts the neuroprotective effect of sulfate. Ischemia patients with higher serum sulfate levels are prone to have smaller infarcts, alleviated severity assessments, and better clinical outcomes. This study unearths an undocumented protective cerebral response against ischemia that might be targeted for ischemic stroke treatment.

本文使用的Yeasen产品

购物车
客服
转染试用